241 related articles for article (PubMed ID: 7419370)
1. Clinical pharmacology of the anterior segment.
Int Ophthalmol Clin; 1980; 20(3):1-194. PubMed ID: 7419370
[No Abstract] [Full Text] [Related]
2. [Selected ophthalmological aspects of clinical pharmacology (author's transl)].
Augustyniak E
Klin Oczna; 1977 Apr; 47(4):195-8. PubMed ID: 853681
[No Abstract] [Full Text] [Related]
3. Ophthalmic medications and pharmacology.
Duvall B; Kershner RM
J Ophthalmic Nurs Technol; 1998; 17(4):151-8. PubMed ID: 9883136
[No Abstract] [Full Text] [Related]
4. Topical ophthalmic cyclosporine: pharmacology and clinical uses.
Lipsky W
Surv Ophthalmol; 2010; 55(2):189; author reply 189. PubMed ID: 20159231
[No Abstract] [Full Text] [Related]
5. Ocular pharmacology and therapeutics.
Evans TM
J Occup Med; 1971 Feb; 13(2):92-6. PubMed ID: 5546201
[No Abstract] [Full Text] [Related]
6. Effect of pathological conditions on drug penetration into the anterior segment.
Foulks GN
Int Ophthalmol Clin; 1980; 20(3):51-9. PubMed ID: 6998900
[No Abstract] [Full Text] [Related]
7. [Ophthalmic medicinal films].
Maĭchuk IuF; Pozdniakov VI; Khromov G; Koneva EB; Starunova LN
Vestn Oftalmol; 1974; (6):73-6. PubMed ID: 4446241
[No Abstract] [Full Text] [Related]
8. Ophthalmic drug use in the OR.
McCoy K
Insight; 1992 Dec; 17(4):10-21. PubMed ID: 1293229
[TBL] [Abstract][Full Text] [Related]
9. Veterinary ophthalmic pharmacology and therapeutics--IA: Introduction.
Gelatt KN
Vet Med Small Anim Clin; 1968 Jun; 63(6):547-53. PubMed ID: 5185595
[No Abstract] [Full Text] [Related]
10. Eyes on New Product Development.
Novack GD
J Ocul Pharmacol Ther; 2019; 35(1):1-2. PubMed ID: 30566384
[No Abstract] [Full Text] [Related]
11. Aqueous formulations and ointments.
MacKeen DL
Int Ophthalmol Clin; 1980; 20(3):79-92. PubMed ID: 6998903
[TBL] [Abstract][Full Text] [Related]
12. Eyes on new product development.
Novack GD
J Ocul Pharmacol Ther; 2014 May; 30(4):301-2. PubMed ID: 24807022
[No Abstract] [Full Text] [Related]
13. [Pharmaco-toxicological aspects of ophthalmological medication].
Cristea E
Rev Chir Oncol Radiol O R L Oftalmol Stomatol Ser Oftalmol; 1985; 29(2):135-40. PubMed ID: 3161128
[No Abstract] [Full Text] [Related]
14. [Clinical experiences in the use of Depersolon eye drops].
Németh B; Farkas E
Orv Hetil; 1965 Oct; 106(43):2037-9. PubMed ID: 5848895
[No Abstract] [Full Text] [Related]
15. Side effects of systemic drugs on the eye and of ophthalmic drugs on the body.
el-Naggar AM; Khalil S
Bull Ophthalmol Soc Egypt; 1972; 65(69):563-6. PubMed ID: 4666816
[No Abstract] [Full Text] [Related]
16. [Clinical findings with Visadron eye drops].
Rütter HH
Med Welt; 1965 Aug; 33():1871-2. PubMed ID: 5320609
[No Abstract] [Full Text] [Related]
17. Drugs and the aging eye.
Dangel ME; Havener WH
Geriatrics; 1981 Mar; 36(3):133-40. PubMed ID: 7215803
[No Abstract] [Full Text] [Related]
18. [Local drug therapy of eye diseases. A short review of present forms of administration].
Brinchmann-Hansen O
Tidsskr Nor Laegeforen; 1980 Apr; 100(12):696-7. PubMed ID: 7414579
[No Abstract] [Full Text] [Related]
19. [Biocidan collyrium].
Parise M; Faucon B
Soins Gynecol Obstet Pueric Pediatr; 1986 Dec-1987 Jan; (67-68):I-II. PubMed ID: 3645807
[No Abstract] [Full Text] [Related]
20. [Polyacrylamide prolongation solution for eye drops].
Maĭchuk IuF; Tishina IF
Vestn Oftalmol; 1971; 6():60-3. PubMed ID: 5144440
[No Abstract] [Full Text] [Related]
[Next] [New Search]
